• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 26 of 100
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
Health
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
By Suzi Ring and BloombergDecember 23, 2021
Del-Kar Pharmacy owner Edwin Muldrow
Health
One Chicago pharmacy avoids creating another drugstore desert by tapping into its deep roots
By Markian Hawryluk and Kaiser Health NewsDecember 22, 2021
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
Health
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By Christiaan HetznerDecember 20, 2021
Biogen headquarters
Health
Biogen slashes cost of Alzheimer’s drug by 50% six months after FDA approval
By Timothy Annett and BloombergDecember 20, 2021
‘Pharma Bro’ drugmaker will pay up to $40 million to settle case over jacking up medicine price by 4,000%
Health
‘Pharma Bro’ drugmaker will pay up to $40 million to settle case over jacking up medicine price by 4,000%
By The Associated PressDecember 8, 2021
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
Magazine
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
By Geoff ColvinDecember 6, 2021
A health worker speaks with a patient in the reception area of a Testaro Covid-19 testing site in the Goodwood district of Cape Town, South Africa,
Health
Omicron vaccine to begin clinical trial in South Africa
By Jeremy KahnDecember 6, 2021
If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
Commentary
If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
By Mark Dybul and Serhat GümrükçüDecember 1, 2021
The most important meeting yet for global pandemic response—and drugmakers
Commentary
The most important meeting yet for global pandemic response—and drugmakers
By Nicole Hassoun and Kaushik BasuNovember 29, 2021
To avoid the superbug pandemic, we must fix the business model for new antibiotics
Commentary
To avoid the superbug pandemic, we must fix the business model for new antibiotics
By Michelle McMurry-Heath and Henry SkinnerNovember 25, 2021
DeepMind and now Isomorphic Laboratories CEO Demis Hassabis
Tech
DeepMind spins out new Alphabet company focused on drug discovery
By Jeremy KahnNovember 4, 2021
Riding high off vaccine wins, Pfizer CEO Albert Bourla delves into his strategy for the year ahead
Features
Riding high off vaccine wins, Pfizer CEO Albert Bourla delves into his strategy for the year ahead
By Erika FryOctober 30, 2021
COVID-19 experimental antiviral drug MOLNUPIRAVIR, two white pills with letters engraved on side, potential experimental WHO Coronavirus cure, pandemic outbreak crisis, isolated on blue background
Health
Merck says poorer countries can produce its new COVID pill without paying royalties
By David MeyerOctober 27, 2021
Robots work in a warehouse
Newsletters
What’s big in A.I. this year
By Jeremy KahnOctober 12, 2021
Merck asks FDA to authorize its breakthrough COVID antiviral pill
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By Matthew Perrone and The Associated PressOctober 11, 2021
1...
  • 24
  • 25
  • 26
  • 27
  • 28
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Today, Emily Blunt is worth $80 million thanks to her Hollywood career—but she actually wanted to be a UN Spanish translator on $80Kplaceholder alt text
By Orianna Rosa RoyleJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.